mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.5 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |